Nivolumab Plus Docetaxel in Patients With Chemotherapy-Naıve Metastatic Castration-Resistant Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial
Eur. J. Cancer 2021 Nov 18;[EPub Ahead of Print], K Fizazi, P González Mella, D Castellano, JN Minatta, A Rezazadeh Kalebasty, D Shaffer, JC Vázquez Limón, HM Sánchez López, AJ Armstrong, L Horvath, DA Bastos, NP Amin, J Li, K Unsal-Kacmaz, M Retz, F Saad, DP Petrylak, RK PachynskiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.